Table 1.

Baseline characteristics according to plasma ADMA levels

	Low plasma ADMA (n = 100)	High plasma ADMA (n = 91)	P value
Age, y	61.0 ± 9.5	60.2 ± 8.4	.559
Men, No. (%)	30 (30.0)	23 (25.3)	.286
Weight, kg	71.3 ± 15.1	77.9 ± 15.7	.004
BMI, kg/m²	28.6 ± 5.2	31.5 ± 6.1	.001
Waist circumference, cm	94.2 ± 12.3	100.5 ± 12.7	.001
Obesity, No. (%)	33 (33.0)	50 (54.9)	.002
SBP, mm Hg	138.7 ± 17.8	136.6 ± 17.9	.427
DBP, mm Hg	85.3 ± 8.8	85.1 ± 12.9	.884
Total cholesterol, mg/dL	202.9 ± 40.7	196.2 ± 41.9	.269
HDL cholesterol, mg/dL	57.3 ± 15.7	51.8 ± 14.6	.012
LDL cholesterol, mg/dL	119.6 ± 34.9	109.6 ± 35.9	.056
Triglycerides, mg/dL	129.8 ± 61.9	178.7 ± 97.8	<.001
Dyslipidemia, No. (%)	13 (13.1)	22 (23.9)	.041
Fasting glucose, mg/dL	100.6 ± 37.5	108.7 ± 37.4	.139
CVD, No. (%)	10 (10)	12 (13.2)	.322
Metabolic syndrome, No. (%)	28 (28)	61 (67)	<.001
Type 2 DM, No. (%)	27 (27.0)	42 (46.2)	.005
Smoking, No. (%)	7 (7.0)	12 (13.2)	.118
Family history of CVD, No. (%)	19 (19.0)	14 (15.4)	.321
Uric acid, mg/dL	5.4 ± 1.5	5.8 ± 1.4	.041
Creatinine, mg/dL	0.9 ± 0.2	0.9 ± 0.2	.419
eGFR, mL/min per 1.732	75.7 ± 15.8	71.9 ± 15.4	.097
eGFR <60 mL/min per 1.732, No. (%)	11 (11.2)	19 (20.9)	.053
Albuminuria, mg/g	14.5 ± 47.9	22.8 ± 67.8	.346
Albuminuria >26 mg/g, No. (%)	7 (7.4)	12 (14.0)	.115
Albuminuria >300 mg/g, No. (%)	1 (1.1)	1 (1.2)	.726
CRP, mg/dL	0.2 ± 0.3	0.9 ± 0.8	<.001
Framingham risk score, %	8.6 ± 7.3	7.9 ± 6.1	.652

ADMA, asymmetric dimethylarginine; BMI, body mass index; CRP, C‐reactive protein; CVD, cardiovascular disease; DBP, diastolic blood pressure; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein; SBP, systolic blood pressure. Data are expressed as mean ± standard deviation.

P value for Student t test of independent samples or χ² test.